NovaBridge Biosciences (NBP)

NovaBridge Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	-	0.63	-1.55	13.86
Revenue Growth (YoY)	-	-	-	-	-94.14%
Cost of Revenue	-	-	-	-	7.31
Gross Profit	-	-	0.63	-1.55	6.55
Selling, General & Admin	31.36	29.66	28.16	28.98	141.67
Research & Development	62.91	21.77	21.45	22.55	190.94
Operating Expenses	94.27	51.43	49.61	51.53	332.6
Operating Income	-94.27	-51.43	-48.98	-53.08	-326.06
Interest & Investment Income	7.61	7.49	9.29	4.95	3.36
Earnings From Equity Investments	-	-1.04	-11.4	-64.71	-57.91
Currency Exchange Gain (Loss)	-0	-5.57	-8.04	-33.75	3.99
Other Non Operating Income (Expenses)	0.07	14.49	-0.05	5.48	4.32
EBT Excluding Unusual Items	-86.59	-36.06	-59.18	-141.1	-372.3
Impairment of Goodwill	-	-	-23.04	-	-
Gain (Loss) on Sale of Investments	-1.75	-	-	-	4.78
Asset Writedown	-	-1.25	-	-	-
Other Unusual Items	-	-12.39	-	-	-
Pretax Income	-88.34	-49.7	-82.22	-141.1	-367.52
Income Tax Expense	-	-	-	0.1	-0.5
Earnings From Continuing Operations	-88.34	-49.7	-82.22	-141.2	-367.02
Earnings From Discontinued Operations	-	27.47	-125.51	-229.85	-
Net Income	-88.34	-22.23	-207.73	-371.05	-367.02
Net Income to Common	-88.34	-22.23	-207.73	-371.05	-367.02
Shares Outstanding (Basic)	96	81	83	83	76
Shares Outstanding (Diluted)	96	81	83	83	76
Shares Change (YoY)	17.96%	-2.45%	0.86%	8.63%	11.11%
EPS (Basic)	-0.92	-0.27	-2.50	-4.50	-4.83
EPS (Diluted)	-0.92	-0.27	-2.50	-4.50	-4.83
Free Cash Flow	-20.6	-106.68	-146.66	-92.32	-157.89
Free Cash Flow Per Share	-0.21	-1.31	-1.76	-1.12	-2.08
Gross Margin	-	-	100.00%	-	47.25%
Operating Margin	-	-	-7749.37%	-	-2353.06%
Profit Margin	-	-	-32868.51%	-	-2648.70%
Free Cash Flow Margin	-	-	-23206.33%	-	-1139.46%
EBITDA	-94.2	-51.17	-48.5	-52.87	-323.89
D&A For EBITDA	0.07	0.26	0.48	0.21	2.17
EBIT	-94.27	-51.43	-48.98	-53.08	-326.06
Revenue as Reported	-	-	0.63	-1.55	13.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q